Bevacizumab plus cisplatin/pemetrexed then bevacizumab alone for unresectable malignant pleural mesothelioma: A Japanese safety study

Takashi Nakano, Kozo Kuribayashi, Masashi Kondo, Masahiro Morise, Yuji Tada, Katsuya Hirano, Morihiko Hayashi, Misa Tanaka, Masataka Hirabayashi

研究成果: Article › 査読